INV-501
N/A
Report date: 2022/05/10 11:42:08
Base Information
Drug NameINV-501
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesinvIOs GmbH
China Registration ClassN/A
Develop Information
Active CompaniesDana-Farber Cancer InstituteinvIOs GmbH
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A